The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells (Q39562043)

13 September 2017

title

The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells (English)

1 reference

13 September 2017

0 references

J Asano

1

1 reference

13 September 2017

A Nakano

2

1 reference

13 September 2017

A Oda

3

1 reference

13 September 2017

H Amou

4

1 reference

13 September 2017

M Hiasa

5

1 reference

13 September 2017

K Takeuchi

6

1 reference

13 September 2017

H Miki

7

1 reference

13 September 2017

S Nakamura

8

1 reference

13 September 2017

T Harada

9

1 reference

13 September 2017

S Fujii

10

1 reference

13 September 2017

K Kagawa

11

1 reference

13 September 2017

I Endo

12

1 reference

13 September 2017

K Yata

13

1 reference

13 September 2017

A Sakai

14

1 reference

13 September 2017

S Ozaki

15

1 reference

13 September 2017

T Matsumoto

16

1 reference

13 September 2017

M Abe

17

1 reference

13 September 2017

publication date

8 April 2011

1 reference

13 September 2017

1 reference

13 September 2017

volume

25

1 reference

13 September 2017

issue

7

1 reference

13 September 2017

page(s)

1182-1188

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.60

13 September 2017

1 reference

7 January 2021

Targeting the bone microenvironment in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.60

7 January 2021

Bone destruction in multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.60

7 January 2021

Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.60

7 January 2021

Cancer and the microenvironment: myeloma-osteoclast interactions as a model

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.60

7 January 2021

Bone marrow microenvironment and the identification of new targets for myeloma therapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.60

7 January 2021

Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.60

7 January 2021

BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.60

7 January 2021

The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.60

7 January 2021

BAFF and APRIL as osteoclast-derived survival factors for myeloma cells: a rationale for TACI-Fc treatment in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.60

7 January 2021

Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.60

7 January 2021

GM-CSF and IL-4 induce dendritic cell differentiation and disrupt osteoclastogenesis through M-CSF receptor shedding by up-regulation of TNF-alpha converting enzyme (TACE).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.60

7 January 2021

The role of the insulin-like growth factor 1 receptor axis in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.60

7 January 2021

The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.60

7 January 2021

Synthesis and evaluation of novel inhibitors of Pim-1 and Pim-2 protein kinases

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.60

7 January 2021

Novel benzylidene-thiazolidine-2,4-diones inhibit Pim protein kinase activity and induce cell cycle arrest in leukemia and prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.60

7 January 2021

The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.60

7 January 2021

Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.60

7 January 2021

Antimyeloma activity of the orally bioavailable dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.60

7 January 2021

Identifiers

DOI

10.1038/LEU.2011.60

1 reference

13 September 2017

1 reference